Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: palbociclib combined with letrozole|DRUG: epirubicin combined with cyclophosphamide and sequential docetaxel
Sponsor: Shengjing Hospital